The groups validated workflows encompass several propriety solutions supplementing traceability and accountability of molecular pathology, pathology and personalized diagnostics from patient to final report. Our facilities share common workflows in maintaining and promoting best practice, with our products supporting International External Quality assurance schemes in molecular pathology. We maintain active involvement and offer full support to the development of Independent EQA schemes offered through the EMQN. To this end we act as an independent validation laboratory for all EMQN molecular pathology schemes, advise on the structure of the materials utilized and biomarker inclusion. This view of auditable transparent operational case metrics is manifest in our remit to offer and support an internal quality management system that aligns with such quality measures.